Botulinum Toxin Injection for the Treatment of Strabismus

Footnotes

Correspondence: Andre Ambrus, MLIS, American Academy of Ophthalmology, Quality and Data Science, P. O. Box 7424, San Francisco, CA 94120-7424. E-mail: [email protected] .

Disclosure(s): All authors have completed and submitted the ICMJE disclosures form.

The author(s) have made the following disclosure(s):

G.B.: Equity owner – Luminopia

S.L.P.: Consultant – Fitz Frames

Funded without commercial support by the American Academy of Ophthalmology .

Prepared by the Ophthalmic Technology Assessment Committee Pediatric Ophthalmology/Strabismus Panel and approved by the American Academy of Ophthalmology’s Board of Trustees April 23, 2021.

HUMAN SUBJECTS: No human subjects were included in this study. All research adhered to the tenets of the Declaration of Helsinki.

No animal subjects were included in this study.

Author Contributions:

Conception and design: Binenbaum, Chang, Heidary, Morrison, Trivedi, Galvin, Pineles

Analysis and interpretation: Binenbaum, Chang, Heidary, Morrison, Trivedi, Galvin, Pineles

Data collection: Binenbaum, Trivedi

Obtained funding: N/A

Overall responsibility: Binenbaum, Chang, Heidary, Morrison, Trivedi, Galvin, Pineles

Comments (0)

No login
gif